Pregnancy outcomes after fertility-sparing management in young women with early endometrial cancer

Obstetrics and Gynecology

Volumn 121, Issue 1, 2013, Pages 136-142

  Park, Jeong Yeol ^a   Seong, Seok Ju ^a   Kim, Tae Jin ^a   Kim, Jae Weon ^a   Kim, Seok Mo ^a   Bae, Duk Soo ^a   Nam, Joo Hyun ^a  

^a not available

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIFENE CITRATE; GONADOTROPIN; MEDROXYPROGESTERONE ACETATE; MEGESTROL ACETATE;

ADULT; CANCER GRADING; CANCER REGRESSION; CANCER STAGING; CONCEPTION; CONSERVATIVE TREATMENT; DISEASE FREE SURVIVAL; EARLY CANCER; ECTOPIC PREGNANCY; ENDOMETRIOID CARCINOMA; FEMALE; FEMALE FERTILITY; FEMALE INFERTILITY; FERTILITY SPARING MANAGEMENT; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; INTRAUTERINE INSEMINATION; MAJOR CLINICAL STUDY; MEDICAL RECORD; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; REVIEW; SPONTANEOUS ABORTION; TREATMENT RESPONSE;

EID: 84872107894     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0b013e31827a0643     Document Type: Review

References (28)

1. Bray F, Loos AH, Oostindier M, Weiderpass E. Geographic and temporal variations in cancer of the corpus uteri: incidence and mortality in pre- and postmenopausal women in Europe. Int J Cancer 2005;117:123-31.
2. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.
3. Jeong NH, Lee JM, Lee SK. Current status in the management of uterine corpus cancer in Korea. J Gynecol Oncol 2010;21:151-62.
4. Jung KW, Park S, Won YJ, Kong HJ, Lee JY, Park EC, et al. Prediction of cancer incidence and mortality in Korea, 2011. Cancer Res Treat 2011;43:12-8.
5. Gallup DG, Stock RJ. Adenocarcinoma of the endometrium in women 40 years of age or younger. Obstet Gynecol 1984;64: 417-20.
6. Evans-Metcalf ER, Brooks SE, Reale FR, Baker SP. Profile of women 45 years of age and younger with endometrial cancer. Obstet Gynecol 1998;91:349-54.
7. Duska LR, Garrett A, Rueda BR, Haas J, Chang Y, Fuller AF. Endometrial cancer in women 40 years old or younger. Gynecol Oncol 2001;83:388-93.
8. Chiva de Agustin L, Lapuente Sastre F, Corraliza Galan V, Granados Galainena L, Gonzalez Martin A, Gonzalez Cortijo L, et al. Conservative management of patients with early endometrial carcinoma: a systematic review. Clin Transl Oncol 2008;10:155-62.
9. Chiva L, Lapuente F, Gonzalez-Cortijo L, Carballo N, Garcia JF, Rojo A, et al. Sparing fertility in young patients with endometrial cancer. Gynecol Oncol 2008;111:S101-4.
10. Erkanli S, Ayhan A. Fertility-sparing therapy in young women with endometrial cancer: 2010 update. Int J Gynecol Cancer 2010;20:1170-87.
11. Frumovitz M, Gershenson DM. Fertility-sparing therapy for young women with endometrial cancer. Expert Rev Anticancer Ther 2006;6:27-32.
12. Ramirez PT, Frumovitz M, Bodurka DC, Sun CC, Levenback C. Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review. Gynecol Oncol 2004;95:133-8.
13. Tangjitgamol S, Manusirivithaya S, Hanprasertpong J. Fertilitysparing in endometrial cancer. Gynecol Obstet Invest 2009;67: 250-68.
14. Mosher WD, Pratt WF. Fecundity and infertility in the United States: incidence and trends. Fertil Steril 1991;56:192-3.
15. Wilcox AJ, Weinberg CR, O'Connor JF, Baird DD, Schlatterer JP, Canfield RE, et al. Incidence of early loss of pregnancy. N Engl J Med 1988;319:189-94.
16. Mills JL, Simpson JL, Driscoll SG, Jovanovic-Peterson L, Van Allen M, Aarons JH, et al. Incidence of spontaneous abortion among normal women and insulin-dependent diabetic women whose pregnancies were identified within 21 days of conception. N Engl J Med 1988;319:1617-23.
17. Stovall TG. Early pregnancy loss and ectopic pregnancy. In: Berek JS, editor. Berek and Novek's gynecology. 14th ed. Philadelphia (PA): Lippincott Williams and Wilkins; 2007. p. 601-35.
18. Goldner TE, Lawson HW, Xia Z, Atrash HK. Surveillance for ectopic pregnancy - United States, 1970-1989. MMWR CDC Surveill Summ 1993;42:73-85.
19. Cunningham FG, Gant NF, Leveno KJ, Gilstrap LC III, Hauth JC, Wenstrom KD. Preterm birth. Williams obstetrics. New York (NY): McGraw-Hill; 2001. p. 689-727.
20. Han AR, Kwon YS, Kim DY, Kim JH, Kim YM, Kim YT, et al. Pregnancy outcomes using assisted reproductive technology after fertility-preserving therapy in patients with endometrial adenocarcinoma or atypical complex hyperplasia. Int J Gynecol Cancer 2009;19:147-51.
21. Mao Y, Wan X, Chen Y, Lv W, Xie X. Outcomes of conservative therapy for young women with early endometrial adenocarcinoma. Fertil Steril 2010;93:283-5.
22. Chao AS, Chao A, Wang CJ, Lai CH, Wang HS. Obstetric outcomes of pregnancy after conservative treatment of endometrial cancer: case series and literature review. Taiwan J Obstet Gynecol 2011;50:62-6.
23. Shirali E, Yarandi F, Eftekhar Z, Shojaei H, Khazaeipour Z. Pregnancy outcome in patients with stage 1a endometrial adenocarcinoma, who conservatively treated with megestrol acetate. Arch Gynecol Obstet 2012;285:791-5.
24. Sovino H, Sir-Petermann T, Devoto L. Clomiphene citrate and ovulation induction. Reprod Biomed Online 2002;4:303-10.
25. Althuis MD, Moghissi KS, Westhoff CL, Scoccia B, Lamb EJ, Lubin JH, et al. Uterine cancer after use of clomiphene citrate to induce ovulation. Am J Epidemiol 2005;161:607-15.
26. Silva Idos S, Wark PA, McCormack VA, Mayer D, Overton C, Little V, et al. Ovulation-stimulation drugs and cancer risks: a longterm follow-up of a British cohort. Br J Cancer 2009;100:1824-31.
27. Jensen A, Sharif H, Kjaer SK. Use of fertility drugs and risk of uterine cancer: results from a large Danish population-based cohort study. Am J Epidemiol 2009;170:1408-14.
28. Dor J, Lerner-Geva L, Rabinovici J, Chetrit A, Levran D, Lunenfeld B, et al. Cancer incidence in a cohort of infertile women who underwent in vitro fertilization. Fertil Steril 2002;77:324-7.